Different activities are conducted to reduce pretreatment intensity of allogeneic hematopoietic stem cell transplantation therapy for 15 cases of ETO fusion gene positive acute myeloid leukemia patients. The gene discussed is RUNX1T1; the disease is acute myeloid leukemia.